https://www.arcorisbio.com/  

8952 Schlieren, Wagistrasse 18

 contact@arcorisbio.com

Kits and custom solutions for RNA FISH, Immunofluorescence, IHC, FACS and more.

https://www.athebio.com/  

8952 Schlieren, Grabenstrasse 11a

  +41 44 508 08 28
 hello@athebio.com

Athebio develops advanced binding molecules based on repeat proteins to help drug developers fill their pipelines with innovative drug candidates.

http://cdr-life.com/  

8810 Horgen, Tödistrasse 46

 info@cdr-life.com

CDR-Life is a Zurich-based biotech company that discovers and develops innovative medicines for the treatment of high need diseases. We invent and develop therapeutic antibody fragments with a focus on immuno-oncology and ophthalmology.

http://www.cellerys.com/  

8952 Schlieren, Wagistrasse 21

Cellerys is a spin-off from University Hospital and University of Zurich. The company develops new therapies against Multiple Sclerosis (MS).

https://centenara.com/  

8952 Schlieren, Wagistrasse 18

 +41 44 730 12 90
 info@centenara.com

Centenara Labs develops and invests in therapies that target geriatric diseases. Our goal is to expand healthspan, promoting overall health, well-being and longevity as the population ages. Centenara Labs supports pioneers in the field of aging to transform their scientific discoveries into medicines. We are building a product pipeline comprised of potential breakthrough therapeutics that treat diseases of aging and help reduce the growing strain on global healthcare systems as the world’s population ages.

https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor  

8952 Schlieren, Wagistrasse 25

 +41 58 851 80 00

Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.

https://dinamiqs.com/  

8952 Schlieren, Wagistrasse 25

 info@dinamiqs.com

We are a science-driven contract development and manufacturing organization offering end-to-end viral vector manufacturing solutions. We offer customized services for companies and institutions developing innovative genetic medicines. As a science and technology-driven platform, we provide a comprehensive approach to viral vector manufacturing, from lab-scale development to scalable bioreactor implementation, process optimization, formulation, and stringent quality control.

https://dinaqor.com/  

8952 Schlieren, Wagistrasse 25

DiNAQOR’s mission is to develop gene therapy solutions that transform the lives of patients with heart disease. Our novel and innovative gene therapy platform is focused on advancing treatments for patients affected by genetic cardiomyopathies, a disease of the heart muscle that can lead to heart failure.

https://discopharma.de  

8952 Schlieren, Wagistrasse 25

Disco Pharmaceuticals is a young ETH spin-off company based in Zurich/Switzerland and Cologne/Germany. We leverage a novel mass spectrometric technology to investigate processes that are fundamental to cancer biology. We combine methodologies in cell biology, biochemistry, mass spectrometry with computational tools to identify proteins selectively expressed on cancer cells. Our ultimate goal is to develop innovative therapies for cancers with high unmet clinical need.

http://evax.ch  

8952 Schlieren, Wagistrasse 21

 hello@evax.ch

We are a spin-off company of the University of Zurich, transferring human standards of care into horses. Our research team develops therapeutical vaccines to treat chronic diseases, allergies and respiratory diseases. Our vision is to address diseases in horses with modern research to contribute to the growing knowledge in the pharmaceutical industry.